Mastery In Diabetes Management: New Diabetes Diagnosis Criteria Req'd For Asian Patients?

Mastery in Diabetes Management: New Diabetes Diagnosis Criteria Req'd for Asian Patients?

Mastery in Diabetes Management: New Diabetes Diagnosis Criteria Req'd for Asian Patients?

Nina Suda, MD
Nina Suda, MD, of Albert Einstein College of Medicine and Montefiore Medical Center in New York, spoke with MedPage Today at AACE 2017, the annual meeting of the American Association of Clinical Endocrinologists, about a case study involving a young Southeast Asian woman presenting with newly diagnosed type 2 diabetes and advanced diabetic nephropathy. Suda's full poster may be downloaded by clicking here.
Following is a transcript of her remarks:
The title of my poster is 'Newly diagnosed insulin-dependent diabetic nephropathy: Do we need different criteria for screening and diagnosis of diabetes in South-East Asians?'
This was a 27-year-old female, she was Sri Lankan, and she came to us with a neck abscess that she had been complaining of for two weeks. She initially presented to an urgent care center and they had said, "Here's some amoxicillin, Advil -- it should get better over time." Unfortunately, it didn't and then she came to Montefiore Medical Center where she presented in the ED, and with which she complained of an abscess that was growing.
What we do know about her is that she was diagnosed with hypertension two years ago. This was on a routine physical. She had seen her primary care doctor, she told us, and they started her on Enalapril. She's been completely compliant with it. So, the only meds that she was taking was the amoxicillin and the Advil, which was for the abscess that she had for about a week. She said that she was on no other medications.
Her family, they didn't have any medical conditions other than diabetes that were diagnosed, and a Continue reading

Rate this article
Total 1 ratings
Study confirms link between high blood pressure and diabetes

Study confirms link between high blood pressure and diabetes

A new study has confirmed people with high blood pressure have a much greater chance of developing diabetes.
The study looked at the health records of four million adults in the United Kingdom and clarified earlier research which had been inconclusive.
But the jury is still out on whether diabetes is actually caused by high blood pressure.
Media player: "Space" to play, "M" to mute, "left" and "right" to seek.
Professor Anoushka Patel, chief scientist at the George Institute for Global Health, said the new data was quite definitive.
She said those with high blood pressure had an almost 60 per cent greater chance of developing diabetes.
"The study used data from routine GP visits, so the data was very reliable and ... a very large ... number of patients were involved," she said.
"We can't say that it's definitely caused by high blood pressure, the study design doesn't allow us to make that conclusion. It's highly suggested."
Professor Patel said the study showed high blood pressure often preceded diabetes and not the other way around.
"The study ... excluded people at the beginning who already had diabetes, so it only included people without diabetes, without heart disease," she said.
"[It] looked at the heart pressure levels then looked at people over a period of time and looked at whether ... they developed diabetes.
"It does actually present that relationship over time. Blood pressure's respective to diabetes rather than the reverse."
However, Professor Patel said researchers would need to do more to prove there was a causal link and investigate whether lowering high bloo Continue reading

Type 1 diabetes | IDDM

Type 1 diabetes | IDDM

Ads by Google
If the body’s insulin production is insufficient or stopped, is called as type-1 diabetes. It is caused by the autoimmune disorder and needs to treat with insulin shots.
Type-1 diabetes is also known as Insulin-Dependent Diabetes Mellitus (IDDM) and juvenile diabetes. It is spelled as type-i diabetes, diabetes one and diabetes 1.
Formerly, it was known as "juvenile diabetes," because it represents a majority of the cases in children, teenagers, or young adults, but now we came to know that it can also affect adults.
Among youth ages younger than ten years, the rate of new cases of type 1 diabetes was 19.7 per 100,000 each year for type 1 diabetes. Among youth aged ten years or older, the rate of new cases was 18.6 per 100,000 each year for type 1 diabetes.
What is Type-1 diabetes?
Only about 10% of the people with diabetes are type 1, remaining 90% are type 2.
What is type 1 diabetes? Type 1 diabetes develops due to the autoimmune destruction of the beta cells in the islet cells of Langerhans in the pancreas. It usually ends up with more or less absolute deficiency of insulin. This destruction process starts a long time before the illness diagnosed. Thus, there exists an opportunity for prevention of diabetes in the future.
To halt or delay pancreas destruction, you should know your type 1 diabetes risk factors and type 1 diabetes symptoms for early type 1 diabetes diagnosis to stop or slow down beta cells destruction.
Type-1 diabetes needs insulin treatment and healthy diabetes lifestyle change for proper blood-glucose level maintenance and to avoid diabete Continue reading

Type 2 diabetes complications - levels of amputations at ‘record high’

Type 2 diabetes complications - levels of amputations at ‘record high’

Diabetes UK has branded the rate of diabetes-related amputations in England a ‘national scandal’, following the publication of new data this week.
It said the total number of major and minor procedures have risen to 23 every day - which is compared with 20 every day between 2010 and 2013.
People with diabetes have a much greater risk of developing problems with their feet, due to the damage raised blood sugars can cause to sensation and circulation.
Data published by Public Health England and the National Cardiovascular Intelligence Network, and analysed by Diabetes UK, revealed the 25,527 major and minor amputations reported during the period 2013 to 2016 to be a record high.
This represents an increase of more than 3,000 total amputations when compared to the previous three-year period of records.
Robin Hewings, Diabetes UK’s head of policy, said: “It’s a huge concern that the number of amputations is increasing.
“Amputations devastate lives and, despite a slight decline in major amputations, a minor amputation can mean someone losing a toe or a foot.
“With good healthcare and support, four out of five of amputations are preventable.
“But nearly a quarter of hospitals in England still do not have a specialist diabetes foot care team.
“The financial impact on our health service is also massive, at least a £1 in every £140 of NHS spending in England goes on foot care for people with diabetes.
“We need to urgently increase the numbers of podiatrists specialising in diabetes and improve the quality of foot checks at GP practices, or people will continue Continue reading

Making the Switch to Medicare with Diabetes

Making the Switch to Medicare with Diabetes

By Pearl Subramanian and Jeemin Kwon
From enrolling in the four types of plans to what they cover, everything you need to know when making the switch to Medicare with diabetes
Despite covering 58 million Americans in 2017, Medicare can be difficult to navigate. The US-government-run program provides health coverage to people over the age of 65 and to those under 65 who have certain disabilities or other conditions. If you are ready to make the switch over to Medicare or know someone who is, this article is a guide on what you need to know for as smooth a transition as possible, understanding that there are plenty of complexities here!
Click to jump to a section:
About Medicare
Though Medicare is often thought of as one big plan, it actually has four different types of coverage:
Part A covers hospital stays, care in nursing facilities, hospice care, and home health care.
Part B covers doctors’ services, non-hospital (outpatient) care, some medical devices and preventative services. People pay a monthly premium for this coverage.
Part C allows people the option to enroll in private insurance plans (HMOs and PPOs) and to receive their benefits under Parts A and B. Those plans are called Medicare Advantage and some offer additional benefits such as dental and vision.
Part D covers prescription drugs and is voluntary.
For more information on decoding and understanding health insurance language, check out diaTribe’s guide here.
Medicare and Diabetes
Medicare covers certain benefits and supplies specific to people with diabetes, including diabetes drugs, blood glucose monitori Continue reading

No more pages to load

Popular Articles

  • New approaches to Diabetes management could transform healthcare in Saudi Arabia

    Saudi Arabia has a high prevalence (17.6%) of type 2 diabetes. 26 February 2017 - Boehringer Ingelheim sponsors the fourth International Conference of Endocrinology and diabetes conference in Riyadh - Saudi Arabia has a high prevalence (17.6%) of type 2 diabetes. It is forecasted that the incidence of the disease will increase to 45.36% in 2030[1] Kingdom Saudi Arabia – Riyadh – The Saudi Soci ...

  • A New Clinical Trial Just Made Diabetes Patients Insulin Independent

    New research involving pancreatic islet cell implants show promise in treating Type 1 Diabetes, a potentially debilitating form of the disease that affects more than a million people in the U.S. This new treatment might just spell the end for T1D. With Promising Potential No matter how modern the world has become, there are certain ailments that continue to persist. One of these is diabetes, and a ...

  • New hope for human patients as scientists reverse type 1 diabetes in mice

    Get short URL A team of scientists from Boston Children's Hospital have reversed type 1 diabetes in mice, leading to hopes that human sufferers of the autoimmune condition may soon be treated using a similar method. Hospital researchers said that all of the mice trialled were successfully cured of type 1 in the short term, while around one-third were cured for the duration of their lives. Previous ...

  • A New Medical Trial Has Seen Type 2 Diabetes "Reversed" in 40% of Patients for 3 Months

    Type 2 diabetes is generally considered to be a chronic health condition that can't be cured once it develops, and can only be managed with a combination of medication and healthy living – assisted by gastric band (bariatric) surgery in some cases. But new research suggests that people may actually be able to beat the disease for set periods, by undertaking an intensive short-term course of medi ...

  • Stem Cells Of Type 1 Diabetes Patients Transformed Into Insulin-Secreting Beta Cells; Research May Lead To New Therapy

    For those living with Type 1 diabetes, the condition is a part of daily life. Insulin shots, blood sugar monitoring, and carb counting become routine, and patients expect them to stay so for the rest of their lives. This form of diabetes currently has no cure, something researchers have been diligently trying to change. The most recent attempt to take down diabetes comes from researchers at Washin ...

  • New metformin may help more patients with type 2 diabetes

    A new study shows that the glucose-lowering effect of metformin - a drug used to treat type 2 diabetes - takes place in the gut and not in the bloodstream. The revelation, published in the journal Diabetes Care, means that a delayed-release form of metformin that the researchers tested could suit the 40% of type 2 diabetes patients who cannot use the current formulation. Metformin (short for metfo ...

  • New Therapies for Patients With Type 2 Diabetes

    Diabetes mellitus is a growing health problem in the United States. According to a recent CDC report, as of 2015, 30.3 million Americans (9.4% of the US population) have diabetes. Of these, 90% to 95% are diagnosed with type 2 diabetes (T2D). This number will likely continue to grow, because an estimated 84.1 million Americans have pre-diabetes, putting them at increased risk of T2D development.1 ...

  • Study: New oral drug helps control glucose, reduces need for insulin in patients with type 1 diabetes

    Study: New oral drug helps control glucose, reduces need for insulin in patients with type 1 diabetes A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes . Principal results were published today in the New England Journal of Medicine of a global Phase 3 clinical trial in patients with ...

  • Symptoms, Diagnosis & Monitoring of Diabetes

    According to the latest American Heart Association's Heart Disease and Stroke Statistics, about 8 million people 18 years and older in the United States have type 2 diabetes and do not know it. Often type 1 diabetes remains undiagnosed until symptoms become severe and hospitalization is required. Left untreated, diabetes can cause a number of health complications. That's why it's so important to b ...

Related Articles